Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate?

Journal of Mammary Gland Biology and Neoplasia

Volumn 5, Issue 1, 2000, Pages 85-94

  DaCosta, S A ^a   Schumaker, L M ^a   Ellis, M J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Breast cancer; Loss of heterozygosity; Mannose 6 phospate insulin like growth factor 2 receptor; Microsatellite instability; Somatic mutation; Tumor suppresor gene

Indexed keywords

SOMATOMEDIN B RECEPTOR;

BRAIN TUMOR; BREAST CANCER; CHROMOSOME; ENDOMETRIUM TUMOR; GASTROINTESTINAL TUMOR; HETEROZYGOSITY LOSS; HUMAN; LIVER CANCER; MICROSATELLITE INSTABILITY; NONHUMAN; REVIEW; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MUTATION; NEOPLASMS; POINT MUTATION; RECEPTOR, IGF TYPE 2;

EID: 0033857523     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009571417429     Document Type: Review

References (72)

1. M6P/IGF2 receptor: A candidate breast tumor suppressor gene
2. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
3. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
4. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
5. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumors
6. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach and colorectum
7. Microsatellite instability and mutation of DNA mismatch repair genes in gliomas
8. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different 'target genes': A study of the TGFbeta RII, IGFII R, and BAX genes
9. Intracellular traffic of the mannose 6-phosphate receptor and its ligands
10. Mannose 6-phosphate receptors and lysosomal enzyme targeting
11. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose-6-phosphate/insulin like growth factor type II receptor
12. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells
13. The mannose 6-phosphata/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene
14. Subregional localization of 20 single-copy loci to chromosome 6 by fluorescence in situ hybridization
15. Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptor
16. The rate of internalization of the mannose 6-phosphate/insulin-like growth factor II receptor is enhanced by multivalent ligand binding
17. Insulin-like growth factor II/cation-independent mannose 6-phosphate receptor and lysosomal enzyme recognition
18. The bovine mannose 6-phosphate/insulin-like growth factor II receptor: The role of arginine residues in mannose 6-phosphate binding
19. The bovine mannose 6-phosphate/insulin-like growth factor II receptor: Localization of the insulin-like growth factor II binding site to domains 5-11
20. Localization of the insulin-like growth factor II (IGF-II) binding/cross-linking site of the IGF-II/mannose 6-phosphate receptor to extracellular repeats 10-11
21. Truncated forms of the insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor encompassing the IGF-II binding site: Characterization of a point mutation that abolishes IGF-II binding
22. M6P/IGF2R as a tumor suppressor gene
23. An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor
24. Interactions of pro-cathepsin D and IGF-II on the mannose-6- phosphate/IGF-II receptor
25. Insulin-like growth factor II (IGF-II) and the IGF-II/mannose-6- phosphate receptor: The myth continues
26. Mutations in the cytoplasmic domain of the 275 kd mannose 6-phosphate receptor differentially alter lysosomal enzyme sorting and endocytosis
27. Mutational analysis of the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor
28. The cytoplasmic tail of the mannose 6-phosphate/insulin-like growth factor-II receptor has two signals for lysosomal enzyme sorting in the Golgi
29. Secretion of soluble insulin-like growth factor-II/mannose 6-phosphate receptor by rat tissues in culture
30. Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor
31. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain
32. Developmental regulation of the soluble form of insulin-like growth factor-II/mannose 6-phosphate receptor in human serum and amniotic fluid
33. Soluble insulin-like growth factor-II/mannose 6-P receptor inhibits deoxyribonucleic acid synthesis in cultured rat hepatocytes
34. Local reduction of organ size in transgenic mice expressing a soluble insulin-like growth factor II/mannose-6-phosphate receptor
35. Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors
36. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor
37. Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid
38. Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction
39. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta 1
40. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin
41. The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface
42. Developmental expression of the IGF-II/mannose 6-phosphate receptor
43. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality
44. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene
45. Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro
46. Evidence that type II insulin-like growth factor receptor is coupled to calcium gating system
47. 2423. Evidence for stimulation acceptor region other than C-terminus of G(iα)
48. Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins
49. The design, expression, and characterization of human insulin-like growth factor-II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose-6-phosphate receptor or IGF-I receptor
50. Insulin receptor activation by IGF-II in breast cancers: Evidence for a new autocrine/paracrine mechanism
51. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
52. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas
53. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma
54. M6P/IGF2R tumor suppressor is mutated in lung cancer
55. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations
56. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing mis-sense mutations in human cancers
57. Mutational analysis of TGFβIIR and IGF2R genes in prostate tumors
58. The genomic structure of the gene encoding M6P/IGF2R and mutation analysis in human cell lines resistant to growth inhibition by TGFβ1
59. Early involvement of 6q in surface epithelial ovarian tumors
60. Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers
61. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer
62. Causes and consequences of microsatellite instability in endometrial carcinoma
63. Microsatellite instability of in situ and invasive sporadic breast cancers in Japanese women
64. Comparative allelotype of in situ and invasive human breast cancer: High frequency of microsatellite instability in lobular breast carcinomas
65. Microsatellite instability within the insulin-like growth factor receptor in human cell lines
66. Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells
67. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus
68. Human insulin-like growth factor type I and type II receptors are not imprinted
69. The insulin-like growth factor type 2 receptor gene is imprinted in the mouse but not in humans
70. Functional polymorphism in the parental imprinting of the human IGF2R gene
71. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor
72. Genomic structure of the human M6P/IGF2 receptor